ACTU vs MDT · $49.0M cap vs P/E 21, rev $36.36B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ACTU currently screens at market cap $49.0M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ACTU and MDT stock pages for the full models.
Not investment advice.